Press release
Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Drugs Market: Transformative Forces Shaping the Dasatinib Drugs Market Landscape in 2025
Dasatinib Drugs Market
What Will the Dasatinib Drugs Industry Market Size Be by 2025?
The market for dasatinib drugs has seen robust growth lately. It's projected that the market will expand from $1.45 billion in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This growth trend during the historical period is due to an upsurge in chronic myeloid leukemia (CML) cases, increased advancement in targeted cancer therapies, more research into tyrosine kinase inhibitors (TKIS), heightened investment in cancer research, and a surge in the number of clinical trials.
What's the Long-Term Growth Forecast for the Dasatinib Drugs Market Size Through 2029?
The market for dasatinib drugs is anticipated to experience robust expansion in the upcoming years, with projections estimating it to reach a valuation of $2 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.6%. This anticipated surge in the forecast period is due to factors such as ramped-up investment in cancer drug development, escalating cases of drug-resistant leukemia, increased availability of generic variants of dasatinib drugs, intensified efforts to reduce chemotherapy's side effects, and heightened awareness and early detection of leukemia. The forecast period will also likely see major trends such as the rise of personalized medicine, introduction of companion diagnostics, creation of new drug formulations, advances in combined therapy methods, and the development of biosimilars.
View the full report here:
https://www.thebusinessresearchcompany.com/report/dasatinib-drugs-global-market-report
What Are the Key Growth Drivers Fueling the Dasatinib Drugs Market Expansion?
The escalation in chronic myeloid leukemia (CML) cases is predicted to stimulate the expansion of the dasatinib drug industry. Chronic myeloid leukemia (CML), a cancer type that impacts bone marrow and blood, is marked by abnormal growth of white blood cells. Factors such as lifestyle demographics, poor nutrition, and elevated environmental risks largely contribute to the rising cases of chronic myeloid leukemia (CML). Dasatinib medicines play a crucial role in managing chronic myeloid leukemia (CML) by inhibiting BCR-ABL (gene fusion), a protein responsible for unregulated cancerous white blood cell growth, resulting from the Philadelphia chromosome mutation. As reported by the American Cancer Society (ACS), a US-based health organization focusing on cancer eradication, the incident rate of chronic myeloid leukemia (CML) in the United States escalated from 8,860 in 2022 to 8,930 in January 2023. Consequently, the escalating numbers of chronic myeloid leukemia (CML) instances are steering the growth of the dasatinib drug industry.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19023&type=smp
What Are the Key Trends Driving Dasatinib Drugs Market Growth?
To proliferate their market presence, provide cost-effective treatment choices, and augment patient access, primary firms in the dasatinib drugs market are focused on producing generic drugs. By providing more affordable options for treatment, generic drugs in the dasatinib market improve patient accessibility, fuel competition, and lower patient healthcare costs. A notable example is Apotex Corp., a pharmaceutical company from Canada, which launched the US's first generic version of Sprycel dasatinib for treating specific leukemia types in adults and children in September 2024. This more affordable alternative enhances access to quality treatment options and signifies a considerable leap in escalating competition and decreasing costs in the dasatinib market.
How Is the Dasatinib Drugs Market Segmented?
The dasatinib drugsmarket covered in this report is segmented -
1) By Product Type: Tablets, Oral Suspension, Other Products
2) By Indication: Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications
3) By End User: Hospitals, Specialty Clinics, Home Healthcare
Subsegments:
1) By Tablets: 20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets
2) By Oral Suspension: 20 mg Or 5 mL Oral Suspension, 40 mg Or 5 mL Oral Suspension
3) By Other Products: Injectable Formulations, Combination Therapies, Generic Dasatinib Products
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19023&type=smp
Which Companies Are Leading the Charge in Dasatinib Drugs Market Innovation?
Major companies operating in the dasatinib drugs market are Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sandoz Group AG, Hetero Drugs Limited, Sun Pharmaceutical Industries Limited, MSN Laboratories Pvt. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., Biocon Limited, Alkem Laboratories Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Mylan N.V., Manus Aktteva Biopharma LLP
Which Regions Are Leading the Global Dasatinib Drugs Market in Revenue?
North America was the largest region in the dasatinib drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dasatinib drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19023
"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Drugs Market: Transformative Forces Shaping the Dasatinib Drugs Market Landscape in 2025 here
News-ID: 4142966 • Views: …
More Releases from The Business Research Company
Impact Of Rising Infrastructure Investment On The Market Growth Due To Increasin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Hydrophilic Swelling Waterstop Market Through 2025?
In recent times, there has been robust growth in the hydrophilic swelling waterstop market size. It is expected to mature from a value of $0.87 billion in 2024 to $0.94 billion in 2025, illustrating a compound…
Emerging Trends to Drive Hot Melt Waterproofing System Market Growth at 7% CAGR …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hot Melt Waterproofing System Market Size Growth Forecast: What to Expect by 2025?
There has been a substantial expansion in the hot melt waterproofing system market in the last few years. It is projected to rise from $2.34 billion in 2024 to $2.52 billion in 2025, with a compound…
High-Pressure Blasting Service Market: Major Trends Reshaping the Future of the …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the High-Pressure Blasting Service Industry Market Size Be by 2025?
The market size for high pressure blasting services has seen substantial growth in the past few years. The market, which is predicted to rise from a value of $3.18 billion in 2024 to $3.40 billion in 2025,…
Impact Of Rising Construction Activities On The Market Growth Due To Increasing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
High Performance Plasterboard Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the last few years, there has been a robust expansion of the high performance plasterboard market size. It's predicted to increase from $13.32 billion in 2024 to $14.21 billion in 2025, showcasing a…
More Releases for Dasatinib
Dasatinib Tablets Market Outlook and Future Projections for 2030
The dasatinib tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Dr …
What industry-specific factors are fueling the growth of the dasatinib drugs market?
The growing incidence of chronic myeloid leukemia (CML) is anticipated to drive the expansion of the dasatinib drug market in the future. Chronic myeloid leukemia (CML) is a form of cancer that affects both the bone marrow and blood, characterized by the abnormal growth of white blood cells. The rising incidence of CML is primarily influenced by factors such…
Emerging Dasatinib Drugs Market Trend 2025-2034: Generic Dasatinib Boosting Comp …
How Is the Dasatinib Drugs Market Projected to Grow, and What Is Its Market Size?
There has been a robust expansion in the market size of dasatinib drugs in the past few years. The market is projected to escalate from a worth of $1.45 billion in 2024 to $1.55 billion in 2025 with a compound annual growth rate (CAGR) of 6.9%. The factors that have contributed to market growth during the…
Dasatinib Tablets Market Outlook and Future Projections for 2030
The dasatinib tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Dasatinib Drugs Market to Grow Significantly by Leading Players 2023 to 2032
The competitive landscape analysis of Dasatinib Drugs Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by…
Dasatinib Drugs Market Expected to Witness a Sustainable Growth by 2030
Dasatinib Drugs Market research report is a professional and an in-depth study available on the market size, share, growth, trends, in addition to industry evaluation. Dasatinib Drugs Market report provides a thorough analysis and competitive analysis by region and added main information like a manufacturing process, raw material and equipment suppliers, various manufacturing associated costs, revenue, historical and futuristic cost, demand and supply data.
Moreover, the study presents a feasible estimate…
